Currently Viewing:
Newsroom
Currently Reading
In Small Amount of Patients, CD4+ T Cells Continue to Decline Despite Being Virally Suppressed
April 18, 2019 – Jaime Rosenberg
Shoshana Lipson Explains How "CGRP & Migraine Community" Supports Patients
April 18, 2019
Is Immunotherapy the Key to Developing an HIV Vaccine?
April 18, 2019 – Wallace Stephens
What We're Reading: Doctors Charged in Opioid Scheme; First US CRISPR Treatment; "Bubble Boy" Disease Cured
April 18, 2019 – AJMC Staff
Dim Light at Night May Help Spread Breast Cancer to Bones
April 18, 2019 – Laura Joszt
Cytomegalovirus May Speed Disease Progression in Cystic Fibrosis
April 17, 2019 – Jaime Rosenberg
Evaluating Revefenacin as a Treatment for COPD
April 17, 2019 – Wallace Stephens
Humana Launches Payment Model to Improve Patient Experience, Outcomes in Cancer Care
April 17, 2019 – Jaime Rosenberg
Bill Seeks to Ban Online Sales of e-Cigarettes, Raise Age to Buy Tobacco to 21
April 17, 2019 – Allison Inserro

What We're Reading: Price Hikes for Older Drugs; FDA Shifts Resources; Opioids and Birth Defects

AJMC Staff
Amid drug shortages and recalls, at least 3 sellers of a widely used blood-pressure medication, valsartan, have raised prices since a series of safety-related recalls of the drug by other manufacturers; the FDA is attempting to conserve dwindling resources during the government shutdown by prioritizing drug applications; researchers are looking into a possible link between prescription opioids and a birth defect called gastroschisis.

Manufacturers Raise Prices of Older Drugs Despite Recalls, Shortages

Amid drug shortages and recalls, at least 3 sellers of a widely used blood-pressure medication, valsartan, have raised prices since a series of safety-related recalls of the drug by other manufacturers, The Wall Street Journal reported. In addition, of the nearly 120 drugs listed by the FDA as currently or recently in shortage, about one-third had price increases after the shortages started, according to the paper’s review of pricing data provided by RELX Group’s Elsevier health-information unit.



FDA Prioritizes Drug Reviews by Shifting Resources

The FDA is attempting to conserve dwindling resources during the government shutdown by prioritizing drug applications, The Washington Post reported. Commissioner Scott Gottlieb, MD, told the paper that the measures will only help preserve funds for a few weeks, and not months, if the shutdown is protracted. The 2018 fees are expected to run out about February 8, and the agency isn’t allowed to collect the 2019 fees during the shutdown, although it can shift funds from other activities.



Researchers Investigating Link Between Birth Defect, Opioids

Researchers are looking into a possible link between prescription opioids and a birth defect called gastroschisis, the Associated Press reported. The condition causes an infant to be born with its intestines outside the stomach due to a hole in the abdominal wall. Most are repaired through surgery. Roughly 1800 such cases happen annually, but the number has been rising and officials don't know why.

Related Articles

Unraveling the Complexity of Drug Shortages
What We're Reading: Drug Prices During Shortages; Healthcare and Small Businesses; Federal Employee Premiums
Gottlieb Touts Launch of New FDA Office to Improve Drug Review Process
What We're Reading: Democrats Aim at Drug Prices; Judge Hears Birth Control Case; ACA Abortion Rule Fight
 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up